Nexalin Technology Inc (NXL)

Ticker: NXL Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nexalin Technology Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
Elson Marilyn Associate to Affiliate
Transaction date
Proposed sale
Price
488.13
Quantity 96,644
Value US$1,927,390
0.5
Shelton Carolyn Hamby Sr. VP - Quality, Regulatory Officer
Transaction date
Purchase
Price
152.37
Quantity 14,494 -46.8%
Value US$777,659
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
122.70
Quantity 5,991 -50.0%
Value US$2,659,948
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
2.98
Quantity 1,000 +0.7%
Value US$2,980
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
2.70
Quantity 1,500 +1.0%
Value US$4,050
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
2.70
Quantity 1,000 +0.7%
Value US$2,700
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
2.50
Quantity 2,000 +1.3%
Value US$5,000
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
2.19
Quantity 500 +0.3%
Value US$1,095
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.95
Quantity 1,000 +0.7%
Value US$950
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
1.75
Quantity 1,000 +0.7%
Value US$1,750
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.71
Quantity 1,619 +1.1%
Value US$1,149
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.62
Quantity 1,000 +0.7%
Value US$620
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.65
Quantity 2,000 +1.4%
Value US$1,300
1.6
Elson Marilyn Ms. Elson serves as CFO Officer Large shareholder
Transaction date
Purchase
Price
1.12
Quantity 9,500 +1.2%
Value US$10,640
1.6
Elson Marilyn Ms. Elson serves as CFO Officer Large shareholder
Transaction date
Purchase
Price
4.15
Quantity 36,000 +4.6%
Value US$149,400
Kazden Alan Non-Executive Director
Transaction date
Purchase
Price
4.15
Quantity 2,500 +2.9%
Value US$10,375
White Mark President/CEO Executive Director
Transaction date
Purchase
Price
4.15
Quantity 2,500 +0.9%
Value US$10,375
Morad Rick Non-Executive Director
Transaction date
Purchase
Price
4.15
Quantity 2,500 +2.4%
Value US$10,375
2.5
Owens David Chief Medical Officer Executive Director
Transaction date
Purchase
Price
4.15
Quantity 2,500 +1.8%
Value US$10,375
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-09-10 2025-09-10 PrS Proposed sale

Associate to Affiliate

96,644
488.13
US$1,927,390
96,644 488.13 US$1,927,390
2025-03-13 2025-03-12 B Purchase

Sr. VP - Quality, Regulatory

Officer
14,494 -46.8%
152.37
US$777,659
14,494 -46.8% 152.37 US$777,659
2025-02-05 2025-02-04 B Purchase

Chief Medical Officer

Executive Director
5,991 -50.0%
122.70
US$2,659,948
5,991 -50.0% 122.70 US$2,659,948
2025-02-04 2025-02-04 B Purchase

Chief Medical Officer

Executive Director
1,000 +0.7%
2.98
US$2,980
1,000 +0.7% 2.98 US$2,980
2025-01-29 2025-01-28 B Purchase

Chief Medical Officer

Executive Director
1,500 +1.0%
2.70
US$4,050
1,500 +1.0% 2.70 US$4,050
2025-01-24 2025-01-23 B Purchase

Chief Medical Officer

Executive Director
1,000 +0.7%
2.70
US$2,700
1,000 +0.7% 2.70 US$2,700
2025-01-24 2025-01-13 B Purchase

Chief Medical Officer

Executive Director
2,000 +1.3%
2.50
US$5,000
2,000 +1.3% 2.50 US$5,000
2024-10-30 2024-10-28 B Purchase

Chief Medical Officer

Executive Director
500 +0.3%
2.19
US$1,095
500 +0.3% 2.19 US$1,095
2024-08-15 2024-08-13 B Purchase

Chief Medical Officer

Executive Director
1,000 +0.7%
0.95
US$950
1,000 +0.7% 0.95 US$950
2024-07-01 2024-06-28 B Purchase

Chief Medical Officer

Executive Director
1,000 +0.7%
1.75
US$1,750
1,000 +0.7% 1.75 US$1,750
2024-06-21 2024-06-18 B Purchase

Chief Medical Officer

Executive Director
1,619 +1.1%
0.71
US$1,149
1,619 +1.1% 0.71 US$1,149
2024-06-12 2024-06-10 B Purchase

Chief Medical Officer

Executive Director
1,000 +0.7%
0.62
US$620
1,000 +0.7% 0.62 US$620
2024-06-12 2024-06-10 B Purchase

Chief Medical Officer

Executive Director
2,000 +1.4%
0.65
US$1,300
2,000 +1.4% 0.65 US$1,300
2022-09-29 2022-09-28 B Purchase

Ms. Elson serves as CFO

Officer Large shareholder
9,500 +1.2%
1.12
US$10,640
9,500 +1.2% 1.12 US$10,640
2022-09-20 2022-09-16 B Purchase

Ms. Elson serves as CFO

Officer Large shareholder
36,000 +4.6%
4.15
US$149,400
36,000 +4.6% 4.15 US$149,400
2022-09-20 2022-09-16 B Purchase Non-Executive Director
2,500 +2.9%
4.15
US$10,375
2,500 +2.9% 4.15 US$10,375
2022-09-20 2022-09-16 B Purchase

President/CEO

Executive Director
2,500 +0.9%
4.15
US$10,375
2,500 +0.9% 4.15 US$10,375
2022-09-20 2022-09-16 B Purchase Non-Executive Director
2,500 +2.4%
4.15
US$10,375
2,500 +2.4% 4.15 US$10,375
2022-09-20 2022-09-16 B Purchase

Chief Medical Officer

Executive Director
2,500 +1.8%
4.15
US$10,375
2,500 +1.8% 4.15 US$10,375